Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Cyclosporine Treatment of Intractable Colitis in Chronic Granulomatous Disease.

Phipatanakul W, Winkelstein JA, Lake AM.

Pediatr Asthma Allergy Immunol. 2009 Summer;14(2):125-127. No abstract available.

2.

Adults with X-linked agammaglobulinemia: impact of disease on daily lives, quality of life, educational and socioeconomic status, knowledge of inheritance, and reproductive attitudes.

Winkelstein JA, Conley ME, James C, Howard V, Boyle J.

Medicine (Baltimore). 2008 Sep;87(5):253-8. doi: 10.1097/MD.0b013e318187ed81.

3.

X-linked agammaglobulinemia: report on a United States registry of 201 patients.

Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, Conley ME, Cunningham-Rundles C, Ochs HD.

Medicine (Baltimore). 2006 Jul;85(4):193-202.

5.

The health status and quality of life of adults with X-linked agammaglobulinemia.

Howard V, Greene JM, Pahwa S, Winkelstein JA, Boyle JM, Kocak M, Conley ME.

Clin Immunol. 2006 Feb-Mar;118(2-3):201-8. Epub 2005 Dec 22.

PMID:
16377251
6.

Helicobacter cinaedi bacteremia presenting as macules in an afebrile patient with X-linked agammaglobulinemia.

Simons E, Spacek LA, Lederman HM, Winkelstein JA.

Infection. 2004 Dec;32(6):367-8.

PMID:
15597229
7.

Immunodeficiency and infections in ataxia-telangiectasia.

Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM.

J Pediatr. 2004 Apr;144(4):505-11.

PMID:
15069401
8.

The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.

Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME.

Medicine (Baltimore). 2003 Nov;82(6):373-84.

9.

Ocular manifestations of ataxia-telangiectasia.

Farr AK, Shalev B, Crawford TO, Lederman HM, Winkelstein JA, Repka MX.

Am J Ophthalmol. 2002 Dec;134(6):891-6.

PMID:
12470759
10.

Survival of wild polio by a patient with XLA.

Sarpong S, Skolnick HS, Ochs HD, Futatani T, Winkelstein JA.

Ann Allergy Asthma Immunol. 2002 Jan;88(1):59-60.

PMID:
11814279
11.

Cytokine and chemokine dysregulation in hyper-IgE syndrome.

Chehimi J, Elder M, Greene J, Noroski L, Stiehm ER, Winkelstein JA, Sullivan KE.

Clin Immunol. 2001 Jul;100(1):49-56.

PMID:
11414745
12.

Why do some individuals have more infections than others?

Winkelstein JA, Childs B.

JAMA. 2001 Mar 14;285(10):1348-9. No abstract available.

PMID:
11255392
13.

Successful treatment of enterovirus infection with the use of pleconaril in 2 infants with severe combined immunodeficiency.

Nowak-Wegrzyn A, Phipatanakul W, Winkelstein JA, Forman MS, Lederman HM.

Clin Infect Dis. 2001 Jan;32(1):E13-4. Epub 2000 Dec 11.

PMID:
11112666
14.

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group.

O'Brien KL, Swift AJ, Winkelstein JA, Santosham M, Stover B, Luddy R, Gootenberg JE, Nold JT, Eskenazi A, Snader SJ, Lederman HM.

Pediatrics. 2000 Nov;106(5):965-72.

PMID:
11061761
15.

Lymphoid malignancy as a presenting sign of ataxia-telangiectasia.

Loeb DM, Lederman HM, Winkelstein JA.

J Pediatr Hematol Oncol. 2000 Sep-Oct;22(5):464-7.

PMID:
11037863
16.
17.

Chronic granulomatous disease. Report on a national registry of 368 patients.

Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H.

Medicine (Baltimore). 2000 May;79(3):155-69.

18.

Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia.

Lefton-Greif MA, Crawford TO, Winkelstein JA, Loughlin GM, Koerner CB, Zahurak M, Lederman HM.

J Pediatr. 2000 Feb;136(2):225-31.

PMID:
10657830
19.

Bilateral consecutive central corneal perforations associated with hypogammaglobulinemia.

Akpek EK, Haddad RS, Winkelstein JA, Gottsch JD.

Ophthalmology. 2000 Jan;107(1):123-6.

PMID:
10647730
20.

Oligo-/monoclonal gammopathy and hypergammaglobulinemia in ataxia-telangiectasia. A study of 90 patients.

Sadighi Akha AA, Humphrey RL, Winkelstein JA, Loeb DM, Lederman HM.

Medicine (Baltimore). 1999 Nov;78(6):370-81.

21.

Immune constitution of complete DiGeorge anomaly by transplantation of unmobilised blood mononuclear cells.

Bowers DC, Lederman HM, Sicherer SH, Winkelstein JA, Chen AR.

Lancet. 1998 Dec 19-26;352(9145):1983-4. No abstract available.

PMID:
9872250
22.

Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease.

Foster CB, Lehrnbecher T, Mol F, Steinberg SM, Venzon DJ, Walsh TJ, Noack D, Rae J, Winkelstein JA, Curnutte JT, Chanock SJ.

J Clin Invest. 1998 Dec 15;102(12):2146-55.

23.

Consequences of the delayed diagnosis of ataxia-telangiectasia.

Cabana MD, Crawford TO, Winkelstein JA, Christensen JR, Lederman HM.

Pediatrics. 1998 Jul;102(1 Pt 1):98-100.

PMID:
9651420
24.

Recurrent Francisella philomiragia sepsis in chronic granulomatous disease.

Polack FP, Harrington SM, Winkelstein JA, Merz WG, Willoughby RE.

Pediatr Infect Dis J. 1998 May;17(5):442-3. No abstract available.

PMID:
9613671
25.

Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency in common variable immunodeficiency.

Fleischman A, Hershfield MS, Toutain S, Lederman HM, Sullivan KE, Fasano MB, Greene J, Winkelstein JA.

Clin Diagn Lab Immunol. 1998 May;5(3):399-400.

26.

Thymoma and cellular immune deficiency in an adolescent.

Sicherer SH, Cabana MD, Perlman EJ, Lederman HM, Matsakis RR, Winkelstein JA.

Pediatr Allergy Immunol. 1998 Feb;9(1):49-52.

PMID:
9560844
27.

Molecular analysis of the third component of canine complement (C3) and identification of the mutation responsible for hereditary canine C3 deficiency.

Ameratunga R, Winkelstein JA, Brody L, Binns M, Cork LC, Colombani P, Valle D.

J Immunol. 1998 Mar 15;160(6):2824-30.

28.

Primary immunodeficiency diseases in adults.

Sicherer SH, Winkelstein JA.

JAMA. 1998 Jan 7;279(1):58-61. No abstract available.

PMID:
9424046
29.

Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome.

Ameratunga R, Lederman HM, Sullivan KE, Ochs HD, Seyama K, French JK, Prestidge R, Marbrook J, Fanslow WC, Winkelstein JA.

J Pediatr. 1997 Jul;131(1 Pt 1):147-50.

PMID:
9255207
30.

Adenosine deaminase deficiency in adults.

Ozsahin H, Arredondo-Vega FX, Santisteban I, Fuhrer H, Tuchschmid P, Jochum W, Aguzzi A, Lederman HM, Fleischman A, Winkelstein JA, Seger RA, Hershfield MS.

Blood. 1997 Apr 15;89(8):2849-55.

31.

Francisella philomiragia sepsis in chronic granulomatous disease.

Sicherer SH, Asturias EJ, Winkelstein JA, Dick JD, Willoughby RE.

Pediatr Infect Dis J. 1997 Apr;16(4):420-2. No abstract available.

PMID:
9109152
32.

Serum complement determinations in patients with quiescent systemic lupus erythematosus.

Sullivan KE, Wisnieski JJ, Winkelstein JA, Louie J, Sachs E, Choi R, Veksler E, Goldman D, Petri M.

J Rheumatol. 1996 Dec;23(12):2063-7.

PMID:
8970042
33.

Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature.

Fasano MB, Sullivan KE, Sarpong SB, Wood RA, Jones SM, Johns CJ, Lederman HM, Bykowsky MJ, Greene JM, Winkelstein JA.

Medicine (Baltimore). 1996 Sep;75(5):251-61. Review.

34.

Discriminant quantitation of posttransplant hepatic reticuloendothelial function. The impact of ischemic preservation.

Klein AS, Zhadkevich M, Wang D, Margolick JB, Winkelstein JA, Bulkley GB.

Transplantation. 1996 Apr 27;61(8):1156-61.

PMID:
8610410
35.

Regulation of early complement components C3 and C4 in the synovium.

Collins T, Winkelstein JA, Sullivan KE.

Clin Diagn Lab Immunol. 1996 Jan;3(1):5-9.

36.

Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass.

Zehr KJ, Poston RS, Lee PC, Uthoff K, Kumar P, Cho PW, Gillinov AM, Redmond JM, Winkelstein JA, Herskowitz A, et al.

Ann Thorac Surg. 1995 Feb;59(2):328-35.

PMID:
7847945
37.

Immunologic defects in patients with chronic recurrent sinusitis: diagnosis and management.

Sethi DS, Winkelstein JA, Lederman H, Loury MC.

Otolaryngol Head Neck Surg. 1995 Feb;112(2):242-7.

PMID:
7838546
38.

A multiinstitutional survey of the Wiskott-Aldrich syndrome.

Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA.

J Pediatr. 1994 Dec;125(6 Pt 1):876-85.

PMID:
7996359
39.

Characterization and virulence analysis of catalase mutants of Haemophilus influenzae.

Bishai WR, Howard NS, Winkelstein JA, Smith HO.

Infect Immun. 1994 Nov;62(11):4855-60.

40.

Prenatal diagnosis of heterozygous deficiency of the second component of complement.

Sullivan KE, Winkelstein JA.

Clin Diagn Lab Immunol. 1994 Sep;1(5):606-7.

41.

Soluble human complement receptor type 1 inhibits complement-mediated host defense.

Swift AJ, Collins TS, Bugelski P, Winkelstein JA.

Clin Diagn Lab Immunol. 1994 Sep;1(5):585-9.

42.

Prevalence of a mutation causing C2 deficiency in systemic lupus erythematosus.

Sullivan KE, Petri MA, Schmeckpeper BJ, McLean RH, Winkelstein JA.

J Rheumatol. 1994 Jun;21(6):1128-33.

PMID:
7932427
43.

Absence of glomerulonephritis in guinea pigs deficient in the fourth component of complement.

Foltz CJ, Cork LC, Winkelstein JA.

Vet Pathol. 1994 Mar;31(2):201-6.

PMID:
8203083
44.

Transcriptional regulation of the gene for the second component of human complement: promoter analysis.

Sullivan KE, Wu LC, Campbell RD, Valle D, Winkelstein JA.

Eur J Immunol. 1994 Feb;24(2):393-400.

PMID:
8299689
45.

The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure.

Quezado ZM, Hoffman WD, Winkelstein JA, Yatsiv I, Koev CA, Cork LC, Elin RJ, Eichacker PQ, Natanson C.

J Exp Med. 1994 Feb 1;179(2):569-78.

46.

Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog.

Gillinov AM, Redmond JM, Winkelstein JA, Zehr KJ, Herskowitz A, Baumgartner WA, Cameron DE.

Ann Thorac Surg. 1994 Feb;57(2):345-52.

PMID:
7906115
47.

Chronic meningococcemia in a child with a deficiency of the sixth component of complement.

Fasano MB, Sullivan K, Ibsen L, Winkelstein JA.

Pediatr Allergy Immunol. 1993 Nov;4(4):214-6. Review.

PMID:
8298713
48.

Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators.

Gillinov AM, Bator JM, Zehr KJ, Redmond JM, Burch RM, Ko C, Winkelstein JA, Stuart RS, Baumgartner WA, Cameron DE.

Ann Thorac Surg. 1993 Oct;56(4):847-53.

PMID:
8105757
49.

Heparin-coated bypass circuits reduce pulmonary injury.

Redmond JM, Gillinov AM, Stuart RS, Zehr KJ, Winkelstein JA, Herskowitz A, Cameron DE, Baumgartner WA.

Ann Thorac Surg. 1993 Sep;56(3):474-8; discussion 479.

PMID:
8104392
50.

Clinical expression of systemic lupus erythematosus in patients with C4A deficiency.

Petri M, Watson R, Winkelstein JA, McLean RH.

Medicine (Baltimore). 1993 Jul;72(4):236-44.

PMID:
8341140

Supplemental Content

Loading ...
Support Center